Regencell Bioscience Holdings Limited Share Price
NASDAQ: RGCRegencell Bioscience Holdings Limited Stock Performance
Regencell Bioscience Holdings Limited Share Price Today
As of 30 October 2026, Regencell Bioscience Holdings Limited's share price is $6.88. The stock opened at $7.14, compared to its previous close of $7.31. During today's trading session, Regencell Bioscience Holdings Limited's share price traded between $6.82 and $7.19, with an average price of $7.01. Over the past 52 weeks, the stock has recorded a high of $67.90 and a low of $4.57. In terms of performance, Regencell Bioscience Holdings Limited's share price has declined by 77.27% over the last six months and is down 57.43% on a year-on-year basis.
Regencell Bioscience Holdings Limited Share Price Chart
Regencell Bioscience Holdings Limited Annual Profit & Loss
All figures in USD
About Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is an early-stage bioscience company that focuses on research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, specifically ADHD and ASD. Its goal is to save and improve the lives of patients, their families and caregivers and become a market leader for the natural and holistic treatment globally. The company operates and manages its business as a single segment - in the research and development of the company's product candidates.
Regencell Bioscience Holdings Limited Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $6.29 | $6.86 | +10.65% |
Sep 2026 | $5.30 | $6.20 | +13.35% |
Aug 2026 | $6.13 | $5.47 | -11.06% |
Jul 2026 | $6.11 | $6.15 | -0.32% |
Jun 2026 | $24.11 | $6.17 | -74.25% |
May 2026 | $29.13 | $23.96 | -20.83% |
Apr 2026 | $26.80 | $30.27 | +18.78% |
Mar 2026 | $25.75 | $25.48 | -1.05% |
Feb 2026 | $27.40 | $25.75 | +5.51% |
Jan 2026 | $22.55 | $24.41 | +15.66% |
Dec 2025 | $11.91 | $21.10 | +81.12% |
Nov 2025 | $16.68 | $11.65 | -27.91% |